{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:58:02Z","timestamp":1792828682767,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.critrevonc.2008.09.005","type":"journal-article","created":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T22:06:25Z","timestamp":1225836385000},"page":"271-278","source":"Crossref","is-referenced-by-count":188,"title":["Carcinoma of unknown primary (CUP)"],"prefix":"10.1016","volume":"69","author":[{"given":"Nicholas","family":"Pavlidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Fizazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2008.09.005_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0147-0272(79)80019-7","article-title":"Metastases of undetermined source","volume":"4","author":"Krementz","year":"1979","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0959-8049(02)00135-1","article-title":"Epidemiology of unknown primary tumours","volume":"38","author":"Levi","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/1097-0142(19950101)75:1+<353::AID-CNCR2820751317>3.0.CO;2-P","article-title":"Cancer of unknown primary site","volume":"75","author":"Muir","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib4","volume":"vol. VI","author":"Parkin","year":"1992"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib5","volume":"vol. VII","author":"Parkin","year":"1991"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib6","first-page":"1","article-title":"Cancer metastases from an unestablished primary tumor (clinical aspects, diagnosis, treatment)","volume":"4","author":"Komov","year":"1991","journal-title":"Sov Med Rev F Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib7","series-title":"Incidence of cancer in the Netherlands","author":"Visser","year":"1993"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib8","series-title":"NSW Central Cancer Registry. Cancer in New South Wales. Incidence and mortality","author":"Coates","year":"1995"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib9","series-title":"International Classification of Diseases for Oncology (ICD-O)","author":"ICD-O","year":"2000"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib10","first-page":"2363","article-title":"Cancer of unknown primary site","volume":"vol. 56","author":"Greco","year":"2008"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib11","first-page":"4311","article-title":"Unknown primary tumors: establishment of cell lines, identification of chromosomal abnormalities, and implications for a second type of tumor progression","volume":"49","author":"Bell","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib12","first-page":"238","article-title":"The biology of unknown primary tumors","volume":"20","author":"Abbruzzese","year":"1993","journal-title":"Semin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0277-5379(85)90171-3","article-title":"Metastatic adenocarcinoma of unknown primary site: abnormalities of cellular DNA content and survival","volume":"21","author":"Hedley","year":"1985","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib14","first-page":"2563","article-title":"Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin","volume":"15","author":"Pavlidis","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1200\/JCO.2000.18.3.632","article-title":"Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site","volume":"18","author":"Hainsworth","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib16","first-page":"1907","article-title":"Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A hellenic co-operative oncology group study","volume":"18","author":"Briasoulis","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib17","first-page":"1619","article-title":"p53 gene mutation spectrum in human unknown primary tumors","volume":"13","author":"Bar-Eli","year":"1993","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10585-007-9055-0","article-title":"Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target?","volume":"24","author":"Dova","year":"2007","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<81::AID-IJC14>3.0.CO;2-L","article-title":"Microvessel density in unknown primary tumors","volume":"74","author":"Hillen","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2407-5-25","article-title":"Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1","volume":"5","author":"Karavasilis","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib21","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/cncr.21454","article-title":"Matrix metalloproteinases in carcinoma of unknown primary","volume":"104","author":"Karavasilis","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0959-8049(02)00008-4","article-title":"Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma","volume":"38","author":"Tot","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib23","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1158\/1078-0432.CCR-04-2236","article-title":"Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm","volume":"11","author":"Dennis","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(82)91557-4","article-title":"Specific chromosome change, i(12p), in testicular tumours?","volume":"2","author":"Atkin","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1200\/JCO.1995.13.1.274","article-title":"Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site","volume":"13","author":"Motzer","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib26","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.ejca.2007.06.023","article-title":"Switching benchmarks in cancer of unknown primary: from autopsy to microarray","volume":"43","author":"Pentheroudakis","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jama.248.3.340","article-title":"Computed tomography in search of cancer of unknown origin","volume":"248","author":"Karsell","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1148\/radiology.212.2.r99au40543","article-title":"Breast MR imaging in patients with axillary node metastases and unknown primary malignancy","volume":"212","author":"Orel","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0959-8049(99)00077-5","article-title":"18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)","volume":"35","author":"Lassen","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib30","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1023\/A:1013107732572","article-title":"Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management","volume":"12","author":"Rades","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib31","series-title":"Cancer treatment","first-page":"798","article-title":"Metastases on unknown origin","author":"Casciato","year":"1990"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib32","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0959-8049(03)00547-1","article-title":"Diagnostic and therapeutic management of cancer of an unknown primary","volume":"39","author":"Pavlidis","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0959-8049(01)00378-1","article-title":"Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984\u20131992","volume":"38","author":"van de Wouw","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib34","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.1986.4.11.1652","article-title":"Prognostic factors in metastatic carcinoma of unknown primary","volume":"4","author":"Pasterz","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib35","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1200\/JCO.1994.12.6.1272","article-title":"Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients","volume":"12","author":"Abbruzzese","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-104-4-547","article-title":"Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome","volume":"104","author":"Greco","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.annonc.a057688","article-title":"Carcinoma of unknown primary: identification of a treatable subset?","volume":"1","author":"van der","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib38","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/1097-0142(19860915)58:6<1371::AID-CNCR2820580632>3.0.CO;2-L","article-title":"Peritoneal papillary serous carcinoma with long-term survival","volume":"58","author":"Chen","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/1097-0142(19900915)66:6<1091::AID-CNCR2820660602>3.0.CO;2-F","article-title":"Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy","volume":"66","author":"Ransom","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib40","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/1097-0142(19901001)66:7<1461::AID-CNCR2820660704>3.0.CO;2-Z","article-title":"Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin","volume":"66","author":"Ellerbroek","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib41","first-page":"431","article-title":"Axillary metastasis from occult breast carcinoma: diagnosis and management","volume":"61","author":"Jackson","year":"1995","journal-title":"Am Surg"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10434-001-0425-6","article-title":"Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases","volume":"8","author":"Vlastos","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-8140(00)00172-9","article-title":"Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology","volume":"55","author":"Grau","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0360-3016(01)01462-6","article-title":"Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple?","volume":"50","author":"Nieder","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib45","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/1097-0142(19870201)59:3<572::AID-CNCR2820590336>3.0.CO;2-3","article-title":"Metastatic inguinal nodes from an unknown primary neoplasm. A review of 56 cases","volume":"59","author":"Guarischi","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib46","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-109-5-364","article-title":"Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity","volume":"109","author":"Hainsworth","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","article-title":"Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms","volume":"68","author":"Moertel","year":"1991","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2008.09.005_bib48","first-page":"656","article-title":"Forty years experience of treating cancer of unknown primary","volume":"33","author":"Pavlidis","year":"2007","journal-title":"Acta Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib49","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1200\/JCO.2003.12.104","volume":"21","author":"Culine","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib50","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/1097-0142(20010201)91:3<592::AID-CNCR1039>3.0.CO;2-5","article-title":"A randomized phase II trial in patients with carcinoma of an unknown primary site","volume":"91","author":"Dowell","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib51","first-page":"1455","article-title":"5-fluorouracil and leucovorin as second-line chemotherapy in carcinomas of unknown primary site","volume":"21","author":"Culine","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1081\/CNV-100103127","article-title":"Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network","volume":"19","author":"Hainsworth","year":"2001","journal-title":"Cancer Invest"},{"key":"10.1016\/j.critrevonc.2008.09.005_bib53","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1200\/JCO.2006.09.3047","article-title":"Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network","volume":"25","author":"Hainsworth","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808002199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808002199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T02:39:04Z","timestamp":1557887944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842808002199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1040842808002199"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2008.09.005","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}